Name: Glucose Intake and Utilization in Pre-Diabetes and Diabetes: Implications for Cardiovascular Disease (en Inglés)
Price: 138080.00 CLP
Availability: InStock
Author: Watson Ronald Ross,Dokken Betsy
ISBN: 9780128000939

portada Glucose Intake and Utilization in Pre-Diabetes and Diabetes: Implications for Cardiovascular Disease (en Inglés)

Formato

Libro Físico

Editorial

Elsevier Books, Oxford

Autor

Watson Ronald Ross,Dokken Betsy

Idioma

Inglés

N° páginas

442

Encuadernación

Tapa Dura

ISBN13

9780128000939

Glucose Intake and Utilization in Pre-Diabetes and Diabetes: Implications for Cardiovascular Disease (en Inglés)

Watson Ronald Ross,Dokken Betsy (Autor) · Elsevier Books, Oxford · Tapa Dura

Libro Nuevo

$ 138.080

$ 230.130

Ahorras: $ 92.050

40% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Miércoles 05 de Junio y el Lunes 17 de Junio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Glucose Intake and Utilization in Pre-Diabetes and Diabetes: Implications for Cardiovascular Disease (en Inglés)"

This important reference, edited by Ronald Ross Watson and Betsy Dokken, collects the research needed to make the distinct connection between pre-diabetes, diabetes, and cardiovascular disease. Glucose Intake and Utilization in Pre-Diabetes and Diabetes: Implications for Cardiovascular Disease explains the mechanisms of progression from pre-diabetes to diabetes to cardiovascular disease. Since pre-diabetes and diabetes are important cardiovascular disease risk factors, and impaired glucose metabolism among cardiac patients is extremely prevalent, the importance of reviewing pre-diabetes and its involvement in CVD complications is vital as one applies food and glycemic control to slow progress to diabetes and heart disease. The book further focuses on glucose intake and utilization in diabetes, including coverage of diabetes in the development and pathology of cardiovascular disease, risks and epidemiology of cardiovascular problems promoted by diabetes, macrovascular effects and their safety in therapy of diabetics, beta cell biology and therapy of diabetes, and nutrition to modulate diabetes.